GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death

Background Despite the strong evidence concerning carcinogenic roles of glucagon-like peptide 1 receptor (GLP1R), the role of this gene in endometrial cancer (EC) remains elusive. This study investigated the properties of GLP1R on EC in vitro.Methods The expression of GLP1R in EC was detected by RT-...

Full description

Saved in:
Bibliographic Details
Main Authors: Wu Li, Wen Lyu, Songjun Liu, Fan Ruan, Xinmei Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Obstetrics and Gynaecology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/01443615.2023.2301324
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553133680984064
author Wu Li
Wen Lyu
Songjun Liu
Fan Ruan
Xinmei Zhang
author_facet Wu Li
Wen Lyu
Songjun Liu
Fan Ruan
Xinmei Zhang
author_sort Wu Li
collection DOAJ
description Background Despite the strong evidence concerning carcinogenic roles of glucagon-like peptide 1 receptor (GLP1R), the role of this gene in endometrial cancer (EC) remains elusive. This study investigated the properties of GLP1R on EC in vitro.Methods The expression of GLP1R in EC was detected by RT-qPCR, immunohistochemistry, and western blotting. Cell viability, cell cycle, apoptosis, migration, invasion and ferroptosis were assessed through CCK-8, flow cytometry, wound healing, transwell, DCFH-DA and western blotting, respectively.Results We found that GLP1R was up-regulated in EC than normal specimens. It had the highest expression in AN3CA cells. Cell viability, migration and invasion were significantly reduced, while cell cycle arrest and apoptosis were induced following GLP1R knockdown. The malignant biological behaviours of AN3CA cells were investigated when treated with exendin-4 (GLP1R agonist). Moreover, GLP1R lowered intracellular ROS level and expression of SLC7A11, and FTH1, but mitigated GPX4 expression in AN3CA cells.Conclusion In a word, GLP1R was up-regulated in EC and its up-regulation facilitated the proliferative and metastatic potentials, and protected cells from ferroptosis, thereby accelerating EC progression. These data emphasised the potency of GLP1R as a therapeutic agent against EC.
format Article
id doaj-art-23dc6a07eb404f29b19f4aeb780f7ad3
institution Kabale University
issn 0144-3615
1364-6893
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Obstetrics and Gynaecology
spelling doaj-art-23dc6a07eb404f29b19f4aeb780f7ad32025-01-09T12:13:17ZengTaylor & Francis GroupJournal of Obstetrics and Gynaecology0144-36151364-68932024-12-0144110.1080/01443615.2023.2301324GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell deathWu Li0Wen Lyu1Songjun Liu2Fan Ruan3Xinmei Zhang4Department of Gynecology, Women’s Hospital School of Medicine Zhejiang University, Hangzhou City, ChinaDepartment of Gynecology, Tongde Hospital of Zhejiang Province, Hangzhou City, ChinaDepartment of Gynecology, Tongde Hospital of Zhejiang Province, Hangzhou City, ChinaDepartment of Gynecology, Tongde Hospital of Zhejiang Province, Hangzhou City, ChinaDepartment of Gynecology, Women’s Hospital School of Medicine Zhejiang University, Hangzhou City, ChinaBackground Despite the strong evidence concerning carcinogenic roles of glucagon-like peptide 1 receptor (GLP1R), the role of this gene in endometrial cancer (EC) remains elusive. This study investigated the properties of GLP1R on EC in vitro.Methods The expression of GLP1R in EC was detected by RT-qPCR, immunohistochemistry, and western blotting. Cell viability, cell cycle, apoptosis, migration, invasion and ferroptosis were assessed through CCK-8, flow cytometry, wound healing, transwell, DCFH-DA and western blotting, respectively.Results We found that GLP1R was up-regulated in EC than normal specimens. It had the highest expression in AN3CA cells. Cell viability, migration and invasion were significantly reduced, while cell cycle arrest and apoptosis were induced following GLP1R knockdown. The malignant biological behaviours of AN3CA cells were investigated when treated with exendin-4 (GLP1R agonist). Moreover, GLP1R lowered intracellular ROS level and expression of SLC7A11, and FTH1, but mitigated GPX4 expression in AN3CA cells.Conclusion In a word, GLP1R was up-regulated in EC and its up-regulation facilitated the proliferative and metastatic potentials, and protected cells from ferroptosis, thereby accelerating EC progression. These data emphasised the potency of GLP1R as a therapeutic agent against EC.https://www.tandfonline.com/doi/10.1080/01443615.2023.2301324Endometrial cancerGLP1Rferroptosis
spellingShingle Wu Li
Wen Lyu
Songjun Liu
Fan Ruan
Xinmei Zhang
GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
Journal of Obstetrics and Gynaecology
Endometrial cancer
GLP1R
ferroptosis
title GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
title_full GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
title_fullStr GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
title_full_unstemmed GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
title_short GLP1R boosts survival, migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
title_sort glp1r boosts survival migration and invasion of endometrial cancer cells and protects against ferroptotic cell death
topic Endometrial cancer
GLP1R
ferroptosis
url https://www.tandfonline.com/doi/10.1080/01443615.2023.2301324
work_keys_str_mv AT wuli glp1rboostssurvivalmigrationandinvasionofendometrialcancercellsandprotectsagainstferroptoticcelldeath
AT wenlyu glp1rboostssurvivalmigrationandinvasionofendometrialcancercellsandprotectsagainstferroptoticcelldeath
AT songjunliu glp1rboostssurvivalmigrationandinvasionofendometrialcancercellsandprotectsagainstferroptoticcelldeath
AT fanruan glp1rboostssurvivalmigrationandinvasionofendometrialcancercellsandprotectsagainstferroptoticcelldeath
AT xinmeizhang glp1rboostssurvivalmigrationandinvasionofendometrialcancercellsandprotectsagainstferroptoticcelldeath